FDMT - CIK 0001650648
4D Molecular Therapeutics, Inc. has filed 397 documents with the SEC between 2015 and 2026. The most frequent type is insider trade (121 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Employee stock plan | S-8 | 2024-02-29 | - |
| Insider trade | 4 | 2024-02-29 | 2024-02-27 |
| Annual report | 10-K | 2024-02-29 | 2023-12-31 |
| Major company event | 8-K | 2024-02-29 | 2024-02-29 |
| Insider trade | 4 | 2024-02-21 | 2024-02-16 |
| Passive ownership stake (update) | SC 13G/A | 2024-02-14 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-02-14 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-02-14 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-02-14 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-02-14 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-02-13 | - |
| Insider trade | 4 | 2024-02-12 | 2024-02-08 |
| Insider trade | 4 | 2024-02-12 | 2024-02-08 |
| Major company event | 8-K | 2024-02-09 | 2024-02-06 |
| Insider sale notice | 144 | 2024-02-08 | - |
| Insider sale notice | 144 | 2024-02-08 | - |
| Prospectus supplement | 424B5 | 2024-02-08 | - |
| Free writing prospectus | FWP | 2024-02-07 | - |
| Insider trade | 4 | 2024-02-07 | 2024-02-05 |
| 3/A | - | 2024-02-07 | 2024-02-07 |
| Prospectus supplement | 424B5 | 2024-02-05 | - |
| S-3ASR | - | 2024-02-05 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-01-25 | - |
| Insider trade | 4 | 2024-01-25 | 2024-01-23 |
| Insider sale notice | 144 | 2024-01-23 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-01-08 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-01-08 | - |
| Insider trade | 4 | 2024-01-08 | 2023-12-15 |
| Insider sale notice | 144 | 2024-01-05 | - |
| Insider trade | 4 | 2024-01-05 | 2024-01-04 |
| Insider sale notice | 144 | 2024-01-04 | - |
| Major company event | 8-K | 2024-01-04 | 2024-01-01 |
| Insider sale notice | 144 | 2023-12-18 | - |
| Insider sale notice | 144 | 2023-12-15 | - |
| Insider trade | 4 | 2023-12-13 | 2023-12-11 |
| Insider trade | 4 | 2023-12-13 | 2023-12-11 |
| Insider trade | 4 | 2023-12-13 | 2023-12-11 |
| Insider trade | 4 | 2023-12-13 | 2023-12-11 |
| Insider trade | 4 | 2023-12-13 | 2023-12-11 |
| Major company event | 8-K | 2023-11-22 | 2023-11-16 |
| Major company event | 8-K | 2023-11-09 | 2023-11-09 |
| Quarterly report | 10-Q | 2023-11-09 | 2023-09-30 |
| Insider trade | 4 | 2023-10-03 | 2023-10-01 |
| New insider ownership | 3 | 2023-09-26 | 2023-09-22 |
| Major company event | 8-K | 2023-09-13 | 2023-09-11 |
| EFFECT | - | 2023-08-15 | - |
| Company correspondence | CORRESP | 2023-08-11 | - |
| SEC correspondence | UPLOAD | 2023-08-11 | - |
| Securities registration | S-3 | 2023-08-09 | - |
| Quarterly report | 10-Q | 2023-08-09 | 2023-06-30 |